Table 2.
Echocardiographic and laboratory data
| Without PH | With PH | P value | |||
|---|---|---|---|---|---|
|
| |||||
| N | N | ||||
|
Echocardiographic variables
Mean ± standard deviation |
|||||
|
| |||||
| LV ejection Fraction (%) | 123 | 59.3 ± 5.6 | 20 | 56.8 ± 8.8 | 0.279 |
|
| |||||
| LV end-Diastolic Volume (mL) | 122 | 119.4 ± 41.4 | 20 | 148.4 ± 51.8 | 0.016 |
|
| |||||
| LV end-Systolic Volume (mL) | 122 | 49.1 ± 21.8 | 20 | 67.8 ± 39.1 | 0.020 |
|
| |||||
| E/e’ average | 115 | 10.4 ± 4.4 | 19 | 14.8 ± 8.1 | 0.005 |
|
| |||||
| LA volume index (mL/m²) | 115 | 30.5 + 9.4 | 20 | 39.9 + 15.2 | 0.002 |
|
| |||||
| LV mass index (g/m²) | 121 | 86.2 ± 25.5 | 20 | 97.8 ± 27.5 | 0.118 |
|
| |||||
| RVSP | 81 | 27.3 ± 4.9 | 20 | 48.0 ± 8.9 | <0.001 |
|
| |||||
| RV size | 116 | 3.55 ± 0.5 | 19 | 3.92 ± 0.7 | 0.006 |
|
| |||||
| Presence of valvular disease (n, %) | 123 | 5 (4) | 20 | 3 (15) | 0.083 |
|
| |||||
| Filling pressure (n, %) | 116 | 19 | <0.001 | ||
| Normal | 95 (82) | 6 (32) | |||
| Elevated | 13 (11) | 12 (63) | |||
| Indeterminate | 8 (7) | 1 (5) | |||
|
| |||||
|
Hematologic parameters
Mean ± standard deviation |
|||||
|
| |||||
| WBC (K/μL) | 123 | 14.2 ±22.9 | 20 | 16.8 ± 16.7 | 0.182 |
|
| |||||
| Hemoglobin (g/dL) | 123 | 10.24 ± 1.8 | 20 | 9.6 ± 2.1 | 0.125 |
|
| |||||
| Hematocrit | 123 | 34.9 ± 22.0 | 20 | 29.9 ± 6.3 | 0.048 |
|
| |||||
| Platelet count (K/μL) | 123 | 182.8 ± 153.5 | 20 | 136.7 ± 94.7 | 0.383 |
|
| |||||
| BNP | 117 | 69.8 ± 75.3 | 17 | 276.4 ± 412.5 | 0.003 |
|
| |||||
| NT-ProBNP (pg/mL) | 114 | 356.2 ± 689.1 | 17 | 4999.1 ± 11614.4 | 0.018 |
PH, pulmonary hypertension; LV, left ventricular; LA, left atrial; RVSP, right ventricular systolic pressure; RV, right ventricular; WBC, white blood cell count; BNP, brain natriuretic peptide; NT-ProBNP, N-terminal-pro hormone brain natriuretic peptide